Teva Agrees to Pay $225 Million to Settle U.S. Price-Fixing Charges
The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link
The generic drugmaker’s U.S. unit also must sell the drug line for cholesterol treatment pravastatin. Source link